"Nepal needs mass cervical screening":
This article was originally published in Clinica
Executive Summary
Mass screening, research and awareness" at the community level is needed for the high incidence of cervical cancer in Nepal. So said Sheela Verma, chief consultant gynaecologist at Stupa Community Hospital (SCH) in Boudha, a suburb of Kathmandu and a famous pilgrimage/tourist site. A recent screening programme undertaken by the Nepal Network for Cancer Treatment and Research (NNCTR) screened 19,000 women. 955 women were found to have gynaecological malignancies, and 825 had the disease. Further screening is currently underway at the SCH.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.